Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | PBA-0405 |
| Synonyms | |
| Therapy Description |
PBA-0405 is an NK-cell engager targeting ROR1, which potentially results in NK cell-mediated killing of tumor cells expressing ROR1 (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| PBA-0405 | PBA 0405|PBA0405 | ROR1 Antibody 8 | PBA-0405 is an NK-cell engager targeting ROR1, which potentially results in NK cell-mediated killing of tumor cells expressing ROR1 (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06273852 | Phase I | PBA-0405 | A Study of the Intratumoral Microdose Administration of PBA-0405 in Patients With Solid Tumors | Completed | USA | 0 |